TGFB1 and prostate cancer: To examine whether AICAR affects TGF-β-induced EMT, migration, and invasion activities in prostate cancer cells, 22Rv1 cells were treated with 5 ng/mL TGF-β and various concentrations (0, 0.25, and 0.5 mM) of AICAR.